N/A
Manufactured by Chattem, Inc.
1,547 FDA adverse event reports analyzed
Last updated: 2026-04-15
SELENIUM SULFIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Chattem, Inc.. The most commonly reported adverse reactions for SELENIUM SULFIDE include DRUG INEFFECTIVE, PRURITUS, HAIR COLOUR CHANGES, NO ADVERSE EVENT, ALOPECIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SELENIUM SULFIDE.
Out of 910 classified reports for SELENIUM SULFIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,547 FDA FAERS reports that mention SELENIUM SULFIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, PRURITUS, HAIR COLOUR CHANGES, NO ADVERSE EVENT, ALOPECIA, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Chattem, Inc. in connection with SELENIUM SULFIDE. Always verify the specific product and NDC with your pharmacist.